Evonik
Tuesday, April 22, 2025

The Future of Injectable Drug Delivery: Demystifying Bioabsorbable Polymers

Sorry! This seminar has already taken place. Please see our event calendar for upcoming events.
Back to workshop overview

Overview

Long-acting, complex drug delivery products, particularly those based on microparticles, nanoparticles and implants, are among the most pervasive parenteral products in the pharmaceutical industry. Long-acting injectables that use bioabsorbable polymers for systemic and local drug delivery have improved the lives of millions of patients globally, based on successful outcomes for the treatment of schizophrenia, diabetes, substance abuse, cancer, as well as ocular, rare and hormonal diseases. These products have many advantages including simplification of the drug regimen by decreasing dosing frequency, helping to improve efficacy and treatment adherence.

In this one-day workshop, Evonik’s drug delivery experts will share their experiences and insights on the discovery and development of long-acting injectables, presenting the most advanced polymer-based excipients, products and platforms on the market. They will highlight key properties of bioabsorbable poly(lactide-co-glycolide) polymers and explain their relevance to drug delivery formulations. In addition, our speakers will discuss GMP manufacturing considerations for both parenteral excipients and drug products. Key areas of focus will be product-by-process manufacturing, ocular implants, microparticles and nanoparticles.

What our attendees will learn:
  • Brief history of long acting polymeric injectable drug products on the market, including microparticles and implants
  • Overview of key LG polymer properties and highly specialized polymer grades relevant to drug delivery formulations
  • Recent application trends, including immuno-oncology and ocular drug delivery and future trends
  • Polymeric and lipid nanoparticles
  • Custom polymer and lipid synthesis, parenteral drug services for formulations

Agenda

8:30 a.m. | Registration​ & Breakfast

9:00 a.m. | Welcome & Introduction​

9:15 a.m. | Long-acting Formulations with Bioabsorbable Polymers
Dr. Tom Tice
Senior Director of Global Technical Marketing
Evonik Health Care

10:00 a.m. | Key Regulatory Considerations for a Successful Formulation
Kathryn McCullough
Regulatory Affairs Team
Evonik Health Care

10:30 a.m. | Coffee Break & Networking

10:45 a.m. | Choosing the Right Bioabsorbable Polymer for your Formulation ​
Dr Manish Rane
Associate Director, Technical Sales
Evonik Health Care

11:30 a.m. | Long-acting Formulations – Polymeric Microparticles and Implants
Dr. Tom Tice
Senior Director of Global Technical Marketing
Evonik Health Care

12:15 p.m. | Lunch & Networking

1:15 p.m. | Mechanistic characterization and genAI powered release prediction for QbD of polymeric drug products
Dr. Andrew Clark
Senior Director of Pharmaceutical Science
DigiM Solution

1:45 p.m. | Custom Polymer Synthesis for Parenteral Formulations
Dr. John Tipton
Director, Strategic and Technical Marketing
Evonik Health Care

02:30 p.m. | Coffee Break & Networking

2:45 p.m. | Medicines of the Future using RESOMER®® and LACTEL®® Polymers
Dr. Tom Tice
Senior Director of Global Technical Marketing
Evonik Health Care

3:30 p.m. | Q&A

4:00 p.m. | Wrap-up

Experts

Dr. Thomas R. Tice
Senior Director Technical Global Technical Marketing
Evonik Health Care

Vita
Thomas Tice is internationally recognized for his research and product development of complex parenteral, drug delivery dosage forms based on bioabsorbable polymer excipients. He is known for his accomplishments involving injectable, extended-release microparticles made with bioabsorbable lactide/glycolide polymers designed for systemic and local drug delivery. He was a team leader and core inventor to develop the first commercial, injectable, extended-release microparticle product. This product, a one-month LHRH formulation indicated for the treatment of prostate cancer (Decapeptyl® SR), is still on the market today. He has also served on various US Pharmacopeia expert committees for 17 years, and is currently on the General Chapters Dosage Forms Expert Committee and Excipient Joint Committee.

At Evonik, Dr. Tice, provides scientific support to Evonik’s innovation, sales, product development, research, intellectual property and M&A teams. He earned his BSc in Chemistry and PhD in Biophysics from Syracuse University, New York. He held a postdoctoral fellow position at the University of Alabama at Birmingham (UAB) in Microbiology. He holds 48 US patents with many foreign equivalents and has more than 180 publications, presentations, and invited lectures to his credit. He flew experiments on two Space Shuttle flights.
Dr. Manish Rane
Associate Director Technical Sales
Evonik Health Care

Details

Participation fee:
$50
City/State:
Cambridge, MA
Country:
USA
Seminar language:
English

Venue

The workshop will take place at:
MIT ILP
One Main Street
Cambridge, MA 02142
12th Floor

Your personal contact


E-Mail